Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 723 results for "pfizer"

This Big Pharma Company Raised Its Prices 5 Times in Two Years
Time

This Big Pharma Company Raised Its Prices 5 Times in Two Years

Pfizer: Big Pharma Company Raises Prices 5 Times in Two Years MY ACCOUNT SIGN IN SIGN OUT SUBSCRIBE SUBSCRIBE YOU BROKE MONEY.COM! Dear MONEY Reader, As a regular visitor to MONEY.com, we are sure you enjoy all the great journalism ... Time, 23 hours ago
Pfizer Completes Acquisition of Medivation Minyanville, 56 minutes ago
[x]  
Seeking Alpha

Pfizer Staying Together, Valeant Breaking Up - A Rangeley Capital Portfolio Manager Discussion

Rangeley Capital's portfolio managers Andrew Walker and . host a 15-minute podcast, which you can subscribe to on iTunes , Stitcher , or audioBoom . If you missed the previous episode, then please check out The Monster Is In The Truck! ( VIA / VIAB ...
 Seeking Alpha2 hours ago
Motley Fool

Is This Pfizer's Next Mega-Blockbuster Cancer Drug?

Now that Pfizer has ( NYSE:PFE ) decided to call off its proposed split, all eyes are squarely focused on the pharma giant's growth prospects as a single entity. The good news is that Pfizer is forecast to post modest single-digit top-line growth ...
 Motley Fool23 hours ago
Seeking Alpha

Pfizer's 9% Decline Gives Dividend Investors Buying Opportunity

Pfizer (NYSE: PFE ) has been one of the Dow's worst-performers over the past two months. Since Aug. 1, shares of the Big Pharma giant are down 9%, and sentiment appears to be even more bearish now that the company has decided not to split up. ...
 Seeking Alpha20 hours ago
Motley Fool

Pfizer's Newest Immunotherapy Deal Could Propel This Tiny Biotech to New Heights

Last week, Pfizer (NYSE:PFE) agreed to a deal with privately held biopharma company OncoImmune. It could be worth up to $250 million in up-front and milestone payments if the monoclonal antibody at the center of the licensing agreement succeeds.
 BioSpace1 hour ago Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company  Motley Fool1 day ago
[x]  
Sify

Super Bowl-sized hype, but will the first debate really matter?

Wall Street was lower late Monday morning, dragged down by Pfizer and as investors anxiously await the first US presidential debate to gauge how the candidates plan to shape the economy and policy. Donald Trump's campaign released a new web ad ...
 Equilibrio Informativo7 hours ago US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials  Reuters UK1 day ago PFIZER : Wall Street ends lower  4 Traders1 day ago DEUTSCHE BANK : Pfizer decision hurts shares  4 Traders1 day ago
[x]  
Bio Spectrum Asia

Pfizer quashes break-up plans, to remain as one entity

(Photo courtesy: www.symphonyofheaven.org) Bengaluru: Pfizer Inc. announced that, after an extensive evaluation, the company's Board of Directors and Executive Leadership Team have determined the company is best positioned to maximize future ...
 Bio Spectrum Asia5 hours ago

Breakingviews: Pfizer's non-split

Georgian politicians duke it out on live TV 7:36pm IST - (0:33) Thrills and spills at Australia's jousting... Mon, 26 Sep, 2016 - (1:25) Paris abandons cars for the day to curb... Mon, 26 Sep, 2016 - (1:17) Indonesian yoga ...
 Reuters India21 hours ago

The Pfizer IIT-Delhi Innovation and IP Program announces first round of grant awardees

The innovators/ start-ups will develop prototypes, which when scaled up, aims to improve the quality of lives of millions of people across the country The Pfizer IIT-Delhi Innovation and IP Program, an incubation accelerator initiative co-created ...
 Express Computer India1 hour ago

Pfizer : iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor

iTeos Therapeutics SA, a biotechnology company working with Pfizer Inc. (NYSE: PFE) to develop therapeutics targeting the tumor immune environment, today announced dosing of the first patient in a Phase 1 dose-escalation study of PF-06840003 ...
 4 Traders6 hours ago iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor September 28, 2016iTeos Therapeutics SA, a biotechno‚Äčlogy company working with Pfizer Inc. (NYSE: PFE) to develop therapeutics targeting the tumor immune environment, today announced d  PRWeb4 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less